http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H08119968-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_69108fc12b940ede105638f37f06080b
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07B61-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01J23-44
filingDate 1995-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_359ce8ab38a2a514fbbd44709eab4e60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9fed3e89eb206e5dc2ee8624b5eb7e9c
publicationDate 1996-05-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-H08119968-A
titleOfInvention Method for producing condensed pyridine compounds
abstract (57) [Summary] (Correction) [Structure] 2-Amino-4-hydroxy-6- [2- (4 -Carboxyphenyl) alk-1-en-1-yl] Pyrido [2,3-d] pyrimidines and 2-amino-4 -Hydroxy-6- [2-4-carboxyphenyl) alk-1-yn-1-yl] pyrido [2,3-d] pyrimidines with haloaromatic compounds and unsaturated compounds in the presence of palladium catalysts Manufactured through. [Effect] The above compounds are chemical intermediates for the production of antitumor agents.
priorityDate 1986-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226403044
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234513984
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID243
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394128
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID234513985
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136058922
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID582898
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136485992

Total number of triples: 22.